Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating cardiovascular and cerebrovascular diseases

A technology for cardiovascular and cerebrovascular diseases and drugs, applied in the field of medicine, can solve problems such as arrhythmia, drug resistance, and side effects, achieve good therapeutic effects, prolong hypoxic survival time, and reduce triglycerides and total cholesterol The effect of content

Pending Publication Date: 2016-06-01
徐宝贞
View PDF9 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Most of the medicines for the treatment of cardiovascular and cerebrovascular diseases in the market are western medicines, and there are certain deficiencies, such as easy to produce drug resistance, as the medicine itself for the treatment of arrhythmia can lead to the generation of arrhythmia, and even some medicines have strong Toxic side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating cardiovascular and cerebrovascular diseases
  • Medicine for treating cardiovascular and cerebrovascular diseases
  • Medicine for treating cardiovascular and cerebrovascular diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1 A kind of medicine for the treatment of cardiovascular and cerebrovascular diseases

[0036] The drug is marine algae glycoprotein;

[0037] The marine algae glycoprotein, by weight content, includes 1% sugar and 99% protein;

[0038] The molecular weight is 0.2kDa;

[0039] The sugar is a polysaccharide;

[0040] The marine algae are cyanobacteria;

[0041] The polysaccharides include: glucose, galactose, mannose, rhamnose;

[0042] The protein includes: arginine, lysine, serine, threonine;

Embodiment 2

[0043] Embodiment 2 A kind of medicine for the treatment of cardiovascular and cerebrovascular diseases

[0044] The drug is marine algae glycoprotein;

[0045] Said marine algae glycoprotein, by weight content, comprises sugar 5%, protein 82%,

[0046] The molecular weight is 15kDa;

[0047] The marine algae is: green algae;

[0048] The sugar is a polysaccharide;

[0049] The polysaccharides include: glucose, galactose, mannose, rhamnose;

[0050] The protein includes: arginine, lysine, serine, threonine;

Embodiment 3

[0051] Embodiment 3 A kind of medicine for the treatment of cardiovascular and cerebrovascular diseases

[0052] The drug is marine algae glycoprotein;

[0053] Said marine algae glycoprotein, by weight content, comprises sugar 10%, protein 75%,

[0054] The molecular weight is 5kDa;

[0055] The marine algae are: cyanobacteria;

[0056] The sugar is a polysaccharide;

[0057] The polysaccharides include: glucose, galactose, mannose, rhamnose;

[0058]The protein includes: arginine, lysine, serine, threonine;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention provides medicine for treating cardiovascular and cerebrovascular diseases. The medicine is glycoprotein, mixture of polysaccharide and protein, polypeptide or protein. The medicine has the advantages that the triglyceride and total cholesterol contents of rats can be lowered effectively; the anoxia survival time of mice can be prolonged to reach 70-85 minutes; the microcirculation can be improved, the coronary artery can be expanded, the myocardial blood supply can be improved, the blood flow of the brain and the coronary artery can be increased, the heart rate can be reduced, and the myocardial oxygen consumption index can be lowered to improve myocardial blood metabolism, resist thromboxane, increase high-density lipoprotein, resist vasospasm and reduce platelet aggregation, and the total cholesterol and triglyceride of the blood can be lowered; the medicine is safe, efficient and free of side effect.

Description

technical field [0001] The invention relates to a medicine for treating cardiovascular and cerebrovascular diseases, belonging to the technical field of medicine. Background technique [0002] Cardiovascular and cerebrovascular diseases are collectively referred to as cardiovascular and cerebrovascular diseases, and generally refer to ischemic or hemorrhagic diseases in the heart, brain, and systemic tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, and high blood pressure. , is a common disease that seriously threatens the health of human beings, especially middle-aged and elderly people over 50 years old. Even if the most advanced and perfect treatment methods are applied, more than 50% of survivors of cerebrovascular accidents still cannot take care of themselves completely. The number of people who die from cardiovascular and cerebrovascular diseases is as high as 15 million every year in the world, ranking first among various causes of death. [0003]...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/16A61K31/715A61K31/7012A61P9/00A61P3/06A61P9/10A61P9/12A61K36/02
CPCA61K31/7012A61K31/715A61K36/02A61K36/195A61K36/315A61K36/48A61K36/704A61K36/748A61K38/16A61K2300/00A61K38/02A61K45/06A61P9/00A61K36/03A61K36/04A61K36/05A61K31/4025A61K38/168
Inventor 徐宝贞程潜程龙
Owner 徐宝贞
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com